WebDec 6, 2024 · Orca-T is an investigational new drug with the potential to dramatically reduce the complications of bone marrow transplants such as GvHD and bring curative outcomes to more patients,” said Scott McClellan MD, PhD, Senior Medical Director at Orca Bio. Allogeneic HSCT replaces a patient’s diseased bone marrow with cells from a healthy donor. WebPurpose. This study will evaluate the safety, tolerability, and efficacy of an engineered donor graft ("TregGraft"/"Orca-T", a T-cell-Depleted Graft With Additional Infusion of Conventional T Cells and Regulatory T Cells) in participants undergoing myeloablative allogeneic hematopoietic cell transplant transplantation for hematologic malignancies.
Orca Bio Presents Positive Data Reinforcing Clinical Profile and ...
WebAn allogeneic stem cell transplant has been the best hope for many patients fighting serious illnesses, such as blood cancers, since the procedure was first performed more than 50 years ago. ... Graft-Versus-Host Disease. Published August 2024. FS32. At Orca Bio, we don’t accept these limitations, and we believe patients shouldn’t have to ... WebAug 2, 2024 · Orca-T is a first-in-class high-precision cell therapy that combines purified cells from a matched donor. It is designed to replace a patient's diseased blood and immune system with a healthy one while lowering the risk of developing GvHD and other life-threatening transplant-related side effects. dyson jet focus hot cool
Orca-T Achieves Impressive Outcomes in Hematologic Malignancies
WebFeb 9, 2024 · Orca-T Graft Shows Efficacy, Tolerability in Post-ASCT Myelofibrosis. Feb 9, 2024. Gina Mauro. An expert with Oregon Health & Science University discusses whether … WebApr 4, 2024 · Each graft of [the Orca-T] product has stem cells and immune cells in it. The stem cells are what we need to maintain the graft and [allow the product to] stay in the … WebThe most compelling studies in allo transplant use 2 different strategies to mitigate graft-versus-host disease, making [allogeneic stem cell] transplant more tolerable while maintaining a curative intent of the transplant itself. cse 240b spring 2022